April 2012 Drug Information Update - Pharmacy Benefits ...

More documents

Recommendations

Info

4 mEq/mL, 100 mL vial (NDC 63323-0032-61) Sodium acetate, Hospira 2 mEq/mL, 20 mL vial (NDC 00409-7299-73) 2 mEq/mL, 50 mL vial (NDC 00409-3299-05) 2 mEq/mL, 100 mL vial (NDC 00409-3299-06) Reason for the Shortage • American Regent had temporarily suspended distribution of most drug products including all sodium acetate presentations in April, 2011. • American Regent resumed manufacturing in Shirley, New York in early-May, 2011. • APP has sodium acetate on shortage due to increased demand. • Hospira has sodium acetate on shortage due to increased demand. • Baxter discontinued sodium acetate in June, 2008. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=762 Source: www.ashp.org Phytonadione (Vitamin K) Injection March 29, 2012 Products Affected - Description Vitamin K injection, contains benzyl alcohol, Hospira1,2 1 mg/0.5 mL ampule (NDC 00409-9157-01) 10 mg/mL, 1 mL ampule (NDC 00409-9158-01) Vitamin K injection, contains polysorbate 80 and propylene glycol, Amphastar3-5 1 mg/0.5 mL, SAF-T-JET prefilled syringe (NDC 00548-1240-00) 1 mg/0.5 mL, MINIJET prefilled syringe (NDC 00548-1140-00) Reason for the Shortage • Hospira has vitamin K injection on shortage due to manufacturing delays. • Amphastar has vitamin K injection on shortage due to increased demand. The company has ramped up production in an effort to meet demand. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=852 Source: www.ashp.org Papaverine Injection March 29, 2012 Products Affected - Description Papaverine injection Reason for the Shortage • Bedford and Sandoz have discontinued their papaverine presentations. • American Regent, the sole supplier of papaverine injection, had temporarily suspended distribution of all drug products in April, 2011. • American Regent resumed manufacturing in Shirley, New York in early-May, 2011. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=781 Source: www.ashp.org Nicardipine Hydrochloride Injection March 29, 2012 Products Affected - Description Nicardipine hydrochloride injection, Teva 2.5 mg/mL, 10 mL vials (NDC 00703-8315-03) - discontinued 72
Nicardipine hydrochloride injection, American Regent 2.5 mg/mL, 10 mL vials (NDC 40042-0047-10) Reason for the Shortage • Teva recalled 4 lots nicardipine injection because the product did not meet purity specifications. The recalled lots are 31302508B, 31302510B, 31302957B, 31303195B. • Teva discontinued nicardipine injection in September, 2010. • American Regent had temporarily suspended distribution of all drug products in April, 2011. • American Regent resumed manufacturing in Shirely, New York in early-May, 2011. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=31 Source: www.ashp.org Nalbuphine Injection March 29, 2012 Products Affected - Description Nalbuphine injection, Hospira 10 mg/mL 1 mL ampules (NDC 00409-1463-01) 10 mg/mL, 1 mL Novaplus ampule (NDC 00409-1463-49) 20 mg/mL 1 mL ampules (NDC 00409-1465-01) 20 mg/mL, 1mL Novaplus ampule (NDC 00409-1465-49) Reason for the Shortage • Endo discontinued Nubain in 2008. • Teva discontinued all nalbuphine injections in July, 2010. • Hospira has nalbuphine on shortage due to manufacturing delays. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=665 Source: www.ashp.org Metoclopramide Injection March 29, 2012 Products Affected - Description Metoclopramide injection, Hospira 5 mg/mL, 2 mL vials (NDC 00409-341401) Reason for the Shortage • Baxter had metoclopramide injection on back order due to regulatory issues. Baxter sold some generic injectable products to West-Ward. West-Ward then discontinued the metoclopramide injection in January, 2012. • Teva discontinued metoclopramide injection in February, 2011. • Hospira discontinued metoclopramide ampules in February, 2010, and Carpuject syringes in May, 2009. Hospira is the only manufacturer of metoclopramide injection. Article Link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=611 Source: www.ashp.org Diphenhydramine Hydrochloride for Injection March 29, 2012 Products Affected - Description Diphenhydramine injection, 50 mg/mL, Hospira 1 mL Carpuject syringe (NDC 00409-2290-31) Diphenhydramine injection, 50 mg/mL, Mylan Institutional 10 mL vial (NDC 67457-0124-10) 73
Page 1 and 2:
April 2012 Drug Information Update
Page 3 and 4:
First-Time Generics GENERIC DRUG NA
Page 5 and 6:
GENERAL ANESTHETICS, INJECTABLE MID
Page 7 and 8:
Gruenhaupt, Mark R.Ph. Argus Health
Page 9 and 10:
Statin Drugs - Drug Safety Communic
Page 11 and 12:
Vytorin (ezetimibe/simvastatin) Tab
Page 13 and 14:
low blood sugar (hypoglycemia) in p
Page 15 and 16:
Some women with depression who beco
Page 17 and 18:
Survival increased for all groups o
Page 19 and 20:
finding that it also may reduce the
Page 21 and 22: Syringes (2 mL size), Rx only. NDC
Page 23 and 24: Patheon Pharmaceuticals Inc., Cinci
Page 25 and 26: 50-ct. bottles (NDC 0067-6238-50);
Page 27 and 28: PRODUCT (Class II) 1) Ventolin HFA
Page 29 and 30: Lot #: 0693, Exp: 10/2012 RECALLING
Page 31 and 32: 24 (Display case UPC# 3030045074923
Page 33 and 34: CODE Lot # 139961 RECALLING FIRM/MA
Page 35 and 36: Reason for the Shortage • Teva co
Page 37 and 38: Reason for the Shortage • Ben Ven
Page 39 and 40: Products Affected - Description Gan
Page 41 and 42: 37.5 mg/25 mg, 1000 count (NDC 0078
Page 43 and 44: Acyclovir tablets, Major 400 tablet
Page 45 and 46: 500 mg, 100 count (NDC 63304-0726-0
Page 47 and 48: 750 mg tablets, 100 count (NDC 1013
Page 49 and 50: • Bedford Laboratories has multip
Page 51 and 52: Daunorubicin Hydrochloride Injectio
Page 53 and 54: Ciprofloxacin Immediate-Release Tab
Page 55 and 56: • APP had tobramycin 40 mg/mL pre
Page 57 and 58: • Ben Venue voluntarily suspended
Page 59 and 60: 50 mg/mL, 10 mL vial, package of 10
Page 61 and 62: 2 mL vial, preservative-free (NDC 6
Page 63 and 64: 5 mg single dose vial, package of 1
Page 65 and 66: 20 mL glass ampule, sterile pack (N
Page 67 and 68: 2 mL iSecure syringe (NDC 00406-112
Page 69 and 70: Lidocaine 0.5% Xylocaine 0.5% injec
Page 71: • Teva discontinued all ciproflox
Page 75 and 76: Article link: http://www.ashp.org/D
Page 77 and 78: • Apotex had metformin products u
Page 79: • Covis purchased all rights to F
show all

April 2012 Drug Information Update - Pharmacy Benefits ...

Create successful ePaper yourself

Delete template?

Save as template?